Nanabis signed to 3 pharmaceutical companies for a reason. BOT With zero sales and zero agreements some how has a higher EV than MDC. Nanabis much more advanced and in higher demand than an acne cream imo. Also the ever increasing % in Nanabis sales under SAS. And imo will continue. Successful advanced clinical trials will sky rocket sales of Nanabis imo. Previous MDC investor presentation show where Nanabis (and sales) is headed in not too distant future. And have been waiting for phase2 results from Nanabis since the 20mill $ placement at 90cents purely for this very trial. Long term holders should be rewarded imo.
Could only imagine what the market value would be if a company ipo'd with only this one Nanabis drug going into phase3 trial with sales... would be hundreds of millions in value imo but MDC with everything else it has and nanocelle platform and deals signed only valued at 50mill $.
Nanabis signed to 3 pharmaceutical companies for a reason. BOT...
Add to My Watchlist
What is My Watchlist?